NDC 68094-073-01 - Glycopyrrolate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68094-073
- Requested NDC
- 68094-073-01
- Package NDCs from labels
- 68094-073-01, 68094-073-58
- Manufacturer
- Precision Dose, Inc.
- Effective date
- 2025-08-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glycopyrrolate - Precision Dose, Inc. | Precision Dose, Inc. | 2025-08-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68094-073-01 | Glycopyrrolate | 5 mL in 1 SYRINGE, PLASTIC | SOLUTION | 5 | 3 | |
| 68094-073-58 | Glycopyrrolate | 1 in 1 BAG | SOLUTION | 1 | 3 | |
| 68094-073-58 | Glycopyrrolate | 50 in 1 CASE | SOLUTION | 50 | 3 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68094-073-01 | ML - Milliliter | 68094-073 | a9fc7629-d93c-4e68-8b52-97ba118eecab | 1 | 2025-08-11 |
| 68094-073-58 | ML - Milliliter | 68094-073 | c84bb0bb-b3e9-42a4-b2b5-01a36d9a1fd2 | 1 | 2025-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glycopyrrolate | GLYCOPYRROLATE | Xiromed LLC | 29618edf-39b0-022a-9875-9d865450d318 | 2022-04-12 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Xiromed, LLC | f777c813-3232-d744-8bcf-58e86fb929bd | 2022-04-12 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Hikma Pharmaceuticals USA Inc. | 516cc4f8-3583-4405-ab66-29d4fcc56d05 | 2022-03-23 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Hikma Pharmaceuticals USA Inc. | d5a18d74-0d40-46e2-aa0a-41d18609a536 | 2022-03-04 | Warnings, Adverse reactions | V92SO9WP2I |
| glycopyrrolate | GLYCOPYRROLATE | BE Pharmaceuticals Inc. | d9df3900-a8c2-438b-8971-ba11ff91f90b | 2022-02-24 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Somerset Therapeutics, LLC | a46c5ec1-a1b4-46fc-9b37-8da7f0c983d6 | 2022-01-27 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | AuroMedics Pharma LLC | eaebb511-1738-4d11-b9bb-317a8d41316a | 2021-12-22 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Nivagen Pharmaceuticals, Inc. | 7cb1ecbe-1e7a-4b39-8e1d-0c20f145e177 | 2021-10-29 | Warnings, Adverse reactions | V92SO9WP2I |
| GLYCOPYRROLATE | GLYCOPYRROLATE | Alembic Labs LLC | db178372-51d2-4194-bbe2-da9acb1cfd53 | 2020-12-09 | Warnings, Adverse reactions | V92SO9WP2I |
| Glycopyrrolate | GLYCOPYRROLATE | Civica, Inc. | 9f7f1ebf-58e8-4ae7-8157-1595df8ad6f4 | 2020-02-26 | Warnings, Adverse reactions | V92SO9WP2I |
| Additox | TRIFOLIUM PRATENSE, XANTHOXYLUM FRAXINEUM, PHYTOLACCA DECANDRA, ARSENICUM ALBUM, BELLADONNA, CHELIDONIUM MAJUS, LYCOPODIUM CLAVATUM, PHOSPHORICUM ACIDUM, ASPARTAME, BENZALKONIUM CHLORIDE, FORMALINUM, METHYLENE CHLORIDE, METHYLPARABEN, PROPYLPARABEN, SODIUM BENZOATE, SODIUM CITRATE, TITANIUM DIOXIDE, ZINCUM OXYDATUM | BioActive Nutritional, Inc. | 319ee2fe-58e3-495e-bf0d-df201f6fbb1c | 2018-07-18 | Warnings | A2I8C7HI9T |
| Glycopyrrolate | GLYCOPYRROLATE | Dr. Reddy's Laboratories Limited | 725529e8-9c4b-4108-690a-e4f391439736 | 2016-11-15 | Warnings, Adverse reactions | V92SO9WP2I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.